Key Insights

Highlights

Treatment Research

1 treatments under study, led by Intraarterial Alteplase

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Completed1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05797792Phase 3Completed

CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).

Showing all 1 trials

Research Network

Common Treatments

  • Intraarterial Alteplase1

Active Sponsors

  • Hospital Clinic of Barcelona1

Top Investigators

Related Conditions

  • Stroke Acute Ischemic1
  • Stroke Acute1

Activity Timeline